imiquimod has been researched along with Cancer of Colon in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, R; Chu, X; Feng, C; Fu, R; Jia, D; Li, G; Li, J; Wang, R; Yan, H; Zhang, J | 1 |
| Chao, Y; Chen, G; Chen, J; Chen, Q; Dong, Z; Du, Y; Jin, Q; Liang, C; Liu, Z; Tao, H; Wang, C; Wu, D; Xiao, Z; Xu, J | 1 |
| Dong, Z; Han, X; Liu, Z; Peng, R; Wang, C; Xu, J; Xu, L; Yang, R; Zhu, W; Zhuang, Q | 1 |
| Ando, T; Arioka, Y; Ito, H; Saito, K; Seishima, M | 1 |
| Cen, JP; Chen, XZ; Cheng, H; Jin, N; Mao, XH; Ye, J; Zhou, Q; Zhu, KJ | 1 |
| Aldrich, W; Ponnazhagan, S; Triozzi, PL | 1 |
6 other study(ies) available for imiquimod and Cancer of Colon
| Article | Year |
|---|---|
Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPĪ± Checkpoint Blockade for Efficient Treatment of Colon Cancer.
Topics: Adjuvants, Immunologic; CD47 Antigen; Colonic Neoplasms; Humans; Imiquimod; Immunotherapy; Liposomes; Neoplasms; Toll-Like Receptor 7 | 2023 |
Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses.
Topics: Adjuvants, Immunologic; Alginates; Animals; Antibodies, Neoplasm; Antibodies, Neutralizing; B7-H1 Antigen; Cell Line, Tumor; Colonic Neoplasms; Combined Modality Therapy; Dendritic Cells; Doxorubicin; Female; Gels; Humans; Imiquimod; Immunotherapy; Injections, Intralesional; Lymphocytes, Tumor-Infiltrating; Macrophages; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Oxaliplatin; Tumor Microenvironment | 2020 |
Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
Topics: Animals; Cell Line, Tumor; Chlorophyllides; Colonic Neoplasms; Colorectal Neoplasms; CTLA-4 Antigen; Disease Models, Animal; Female; HeLa Cells; Humans; Imiquimod; Immunotherapy; Mice; Mice, Inbred BALB C; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Porphyrins | 2017 |
Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model.
Topics: Aminoquinolines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Imiquimod; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lymph Nodes; Lymphocytes, Tumor-Infiltrating; Membrane Glycoproteins; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction; Th1 Cells; Thymoma; Thyroid Neoplasms; Time Factors; Toll-Like Receptor 7; Tryptophan; Tumor Burden | 2015 |
Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells.
Topics: Aminoquinolines; Antigen Presentation; Cell Differentiation; Cells, Cultured; Colonic Neoplasms; Condylomata Acuminata; Cytotoxicity, Immunologic; Dendritic Cells; Epitopes, T-Lymphocyte; Female; HLA-A Antigens; HLA-A2 Antigen; Human papillomavirus 11; Humans; Imiquimod; Interferon-gamma; Lipopolysaccharides; Lymphocyte Activation; Monocytes; Oligonucleotides; Oncogene Proteins, Viral; Poly I-C; Th1 Cells; Toll-Like Receptors; Tumor Virus Infections; Uterine Cervical Neoplasms; Viral Vaccines | 2010 |
Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists.
Topics: Aminoquinolines; Animals; Cancer Vaccines; Carcinoembryonic Antigen; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Dendritic Cells; Dependovirus; Female; Gene Expression Regulation; Humans; Imiquimod; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oligodeoxyribonucleotides; T-Lymphocytes, Helper-Inducer; Toll-Like Receptor 7; Toll-Like Receptor 9; Vaccines, Synthetic | 2011 |